(Q34486007)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

review article

1 reference

title

The role of mast cells in functional GI disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Javier Santos

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Mira M Wouters

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

English

0 references

publication date

20 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

155-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Intestinal mast cells in gut inflammation and motility disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Potential effector and immunoregulatory functions of mast cells in mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cell function: a new vision of an old cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cell-orchestrated immunity to pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Molecular regulation of mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Ultrastructural studies of human basophils and mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Piecemeal degranulation as a general secretory mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Food components and irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The belly rules the nose: feeding state-dependent modulation of peripheral chemosensory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Chronic pain treatment: the influence of tricyclic antidepressants on serotonin release and uptake in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Consumption of spicy foods and the prevalence of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Systematic review with meta-analysis: post-infectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Acute experimental stress evokes a differential gender-determined increase in human intestinal macromolecular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Performing colonic mast cell counts in patients with chronic diarrhea of unknown etiology has limited diagnostic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Activated Mast Cells Infiltrate in Close Proximity to Enteric Nerves in Diarrhea-predominant Irritable Bowel Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Relationship between headache and mucosal mast cells in pediatric Helicobacter pylori-negative functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Quantitative evaluation of duodenal eosinophils and mast cells in adult patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Role for protease activity in visceral pain in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Functions and imaging of mast cell and neural axis of the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Innervation of enteric mast cells by primary spinal afferents in guinea pig and human small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Intestinal barrier function and the brain-gut axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Use of oral sodium cromoglycate in persistent diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Management of diarrhoeic type of irritable bowel syndrome with exclusion diet and disodium cromoglycate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Ketotifen therapy for acute ulcerative colitis in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Cromolyn sodium in the management of systemic mastocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

New insights in mast cell modulation by palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Berberine Prevents Intestinal Mucosal Barrier Damage During Early Phase of Sepsis in Rat through the Toll-Like Receptors Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Pathogenesis of irritable bowel syndrome: the mast cell connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Intestinal permeability in children/adolescents with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Evaluation of antral mast cells in nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

The role of colonic mast cells and myenteric plexitis in patients with diverticular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cell tryptase reduces junctional adhesion molecule-A (JAM-A) expression in intestinal epithelial cells: implications for the mechanisms of barrier dysfunction in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

T(84) epithelial cells respond to 5-hydroxytryptamine when grown in serum-free media

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2015-309151

10.1136/GUTJNL-2015-309151

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26194403%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference